SES

Submitted by Anonymous on
2025 ISPE Facility of the Year Awards (FOYA) Category Winners Showcase
2025 ISPE Facility of the Year Awards (FOYA) Category Winners Showcase: 20 Years of Innovation in Facility Excellence

Celebrate 20 years of FOYA with us in this milestone session that honors the past, present, and future of pharmaceutical facility innovation.

Led by Dave DiProspero, this engaging, roundtable-style discussion will feature some of the 2025 FOYA Category Winners and a panel of seasoned FOYA judges.
Submitted by Anonymous on
Membership Meeting and Awards Lunch - Open to All Attendees
The ISPE Membership Meeting and Awards Lunch is open to all In-Person All Access and Essentials Pass Attendees. Meet and hear from the ISPE leadership and colleagues while learning about significant achievements made by the industry in the past year. Celebrate with your peers as the ISPE International Honor Awards are presented and learn about the 2025 Facility of the Year Awards (FOYA) Category Winners & Overall Winner.
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
2025 ISPE International Emerging Leader Hackathon Day 2
Students and recent graduates will be tasked with analyzing a problem statement, acting as a consultant group to help the company solve an issue, to pitch it to a panel of expert judges at the culmination of the Hackathon. At the end of the two days, each team will present a group of judges and industry leaders. The judges will evaluate the presentations, provide feedback to the teams, and identify the best solution.
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
Revolutionizing Regulated Bioanalytical Testing with Robotic Automation
In the rapidly evolving bioanalytical testing landscape, the need for high-throughput and reliable serological assays has underscored significant challenges in data management and regulatory compliance. The amount of data generated by an automated platform presents unique challenges in the regulated environment, as it is key to ensure that samples can be accurately and rapidly traced throughout the workstream.
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
Cross-Program mRNA Process Models with Interpretable Machine Learning
The commercialization of mRNA based COVID vaccines has fulfilled the promise of mRNA science as a new generation of transformative medicines. The potential demand for variant-targeted vaccines of infectious diseases and personalized neoantigen expressing cancer vaccines require rapid process development and supply of mRNAs of newly designed sequences. Predictive in silico tools can be used to reduce the time and cost of process development and recommend optimal RNA process for new sequences.
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
Leveraging Competition to Drive Sustainability
Sanofi has committed to aggressive targets and programs to reduce our Environmental footprint.  Planet Care focuses on 5 main pillars: Carbon, Water, Biodiversity, Ecodesign, and Waste.  The Global Engineering team is responsible for identifying and executing many of the projects across our Manufacturing and Supply sites that will allow us to achieve our Planet Care goals.   Although we have made great strides in our energy efficiency program (reducing consumption by close to 10% since 2021), one of our challenges is continuing to raise the visi
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
Merging, Managing & Scaling Supply Chain Resilience
Astellas Pharma rapidly expanded through strategic acquisitions in advanced modalities and investments in cutting-edge Research and Manufacturing Hubs. However, this rapid growth led to operational inefficiencies, inconsistent processes, limited visibility into third-party dependencies, and underutilized enterprise capabilities—hindering resilience and efficiency.
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
Harness Operational Data to Accelerate Decarbonization
Every pharmaceutical site relies heavily on data, from building management systems monitoring operations to production figures influencing financial decisions. Interpreting this data is critical to measuring real-time energy consumption, identifying opportunities to reduce or reuse energy, and lowering greenhouse gas (GHG) emissions. Adding to the complexity, this data must be translated into actionable financial insights when seeking capital investment.
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
LEED v5: Advancing ESG & Sustainability
The LEED Rating system has long provided a structured pathway for life sciences and manufacturing facilities to meet ambitious ESG and sustainability targets. The newly released v5 places an increased focus on carbon reduction and strengthens requirements for both embodied and operational emissions, helping organizations align with net-zero commitments. As regulatory pressures grow and greater accountability is demanded, LEED v5 supports compliance with evolving disclosure frameworks while enhancing resilience and operational efficiency.
First name
Trudy
Last name
Patterson
Submitted by Trudy Patterson on
Supply Resilience and Lessons Learned from the Pandemic
In this presentation we will share how the Biopharmaceutical Manufacturing Industry is evolving an approach to Supply Resilience based on lessons learned from the Pandemic, the desire of Senior Executives to focus on Supply Resilience in the post-pandemic era, and the need to develop industry-wide solutions that cover how we collaborate across the End-To-End Supply Chain to become aware of and respond to any future Crisis (not just the next Pandemic) that might impact our ability to supply biopharmaceuticals to the people that need them at country, region or global